Musters R J, van der Meulen E T, van der Laarse W J, van Hardeveld C
Institute for Cardiovascular Research Vrije Universiteit, Amsterdam, The Netherlands.
J Mol Cell Cardiol. 1998 Feb;30(2):435-40. doi: 10.1006/jmcc.1997.0617.
We have recently shown that norepinephrine (NE) pretreatment attenuates Ca2+ overloading in cardiac rat trabeculae during metabolic inhibition (MI) with NaCN (2 mmol/l), and improves contractile recovery during a subsequent recovery period (RP). In the present study, we investigated the effects of the continuous presence of NE (1 micro mol/l), i.e. before, during and after MI, on Ca2+ homeostasis maintenance and contractile recovery in the same model at 24 degrees C. In addition, we tested the effects of NE when only present in the rigor period during MI. The continuous presence of NE both before (30 min) and during MI (120 min)+RP (60 min) (group NE-I) significantly increased the proportion of trabeculae that resumed to contract during RP from 46+/-4% (mean+/-s.e.m.) in controls to 82+/-8%. The Ca2+ rise at the end of MI in failing control trabeculae (1.85+/-0.04 micro mol/l) was more than doubled compared to recovering control preparations (0.78+/-0.02 micro mol/l). However, the time-course of the Ca2+ rise during MI in recovering and failing NE-I preparations was similar, and eventually of the same magnitude as observed in failing control preparations (1.6+/-0. 02 and 1.85+/-0.07 micro mol/l, respectively). In contrast, when NE was present only in the rigor period during MI (group NE-II) the proportion of recovering preparations decreased significantly to 27+/-9%. Similar to the control group, recovering and failing preparations in group NE-II could be distinguished by a differential course in the Ca2+ rise during MI. The results show that when NE is present both before and during MI+RP, (i) recovery probability following MI is still improved, in spite of the deleterious effect on contractile recovery of the presence of NE in the rigor during MI, and (ii) there is no relationship between the magnitude of Ca2+ overload during MI and recovery probability during RP.
我们最近发现,去甲肾上腺素(NE)预处理可减轻用2 mmol/l氰化钠(NaCN)进行代谢抑制(MI)时大鼠心脏小梁中的Ca2+超载,并改善随后恢复期(RP)的收缩恢复。在本研究中,我们研究了在24℃下,NE(1 μmol/l)持续存在,即在MI之前、期间和之后,对同一模型中Ca2+稳态维持和收缩恢复的影响。此外,我们测试了NE仅在MI的强直期存在时的作用。NE在MI之前(30分钟)和期间(120分钟)+RP(60分钟)持续存在(NE-I组),显著增加了在RP期间恢复收缩的小梁比例,从对照组的46±4%(平均值±标准误)增加到82±8%。与恢复的对照制剂(0.78±0.02 μmol/l)相比,衰竭的对照小梁在MI结束时的Ca2+升高(1.85±0.04 μmol/l)增加了一倍多。然而,恢复和衰竭的NE-I制剂在MI期间Ca2+升高的时间进程相似,最终幅度与衰竭的对照制剂中观察到的相同(分别为1.6±0.02和1.85±0.07 μmol/l)。相反,当NE仅在MI的强直期存在时(NE-II组),恢复制剂的比例显著下降至27±9%。与对照组相似,NE-II组中恢复和衰竭的制剂可以通过MI期间Ca2+升高的不同过程来区分。结果表明,当NE在MI+RP之前和期间都存在时,(i)尽管NE在MI强直期存在对收缩恢复有有害影响,但MI后的恢复概率仍然提高,(ii)MI期间Ca2+超载的幅度与RP期间的恢复概率之间没有关系。